Jonathan C Fox is of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 23,702 shares of EWTX, which is worth approximately $539,220. The most recent transaction as insider was on Nov 11, 2025, when has been sold 10,700 shares (Common Stock) at a price of $18.64 per share, resulting in proceeds of $199,448. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
93.11% 3M change
118.31% 12M change
Total Value Held $539,220

Jonathan C Fox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2025
BUY
Open market or private purchase
$199,448 $18.64 p/Share
10,700 Added 31.1%
23,702 Common Stock
Oct 01 2025
BUY
Grant, award, or other acquisition
-
728 Added 5.3%
13,002 Common Stock
Jul 01 2025
BUY
Grant, award, or other acquisition
-
858 Added 6.53%
12,274 Common Stock
Apr 01 2025
BUY
Grant, award, or other acquisition
-
559 Added 4.67%
11,416 Common Stock
Dec 26 2023
BUY
Open market or private purchase
$100,970 $9.3 p/Share
10,857 Added 50.0%
10,857 Common Stock

Also insider at

EIDX
Eidos Therapeutics, Inc.
JCF

Jonathan C Fox

San Francisco, CA

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX